CardioNet Inc. (NASDAQ:BEAT) is giving its failed attempt to acquire cardiac monitor developer Biotel Inc. (OTC:BTEL) another shot.
The Conshohocken, Pennsylvania-based wireless cardiac device maker today announced its plans to purchase Eagan, Minnesota-based Biotel Inc. for $11 million, or $3.84 per share, a 156 percent premium over its Nov. 5 closing price of $1.50.
CardioNet and Biotel also agreed to dismiss outstanding litigation between them when the deal closes and expect the transaction to be complete by the end of the year. The merger’s success, however, is still subject to shareholder approval.
The Power Behind Enterprise EHR Software for Large Healthcare Systems
Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems.
CardioNet had first announced plans to buy Biotel in April 2009 for $14 million, but canceled its plans for unspecified reasons. The company may have lost the financial fortitude for the deal after Highmark CMS cut its reimbursement rate for Mobile Cardiac Outpatient Telemetry services substantially from $1,234.07 to just over $700, a setback which precipitated a shareholder lawsuit.
The Biotel acquisition includes its Braemar subsidiary’s wireless event monitor, which “enhances CardioNet’s position in the field of wireless medicine,” according to the company. The deal also enables CardioNet to enter into the clinical services market with the event, Holter and twelve-lead ECG monitoring services of Biotel subsidiary Agility Centralized Research Services, the company said.
Biotel’s shares were up $2.21 to $3.71, or 147 percent, in late morning trading.
The Hidden Administrative Tasks Draining Small Practices
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
The Massachusetts Medical Devices Journal is the online journal of the medical devices industry in the Commonwealth and New England, providing day-to-day coverage of the devices that save lives, the people behind them, and the burgeoning trends and developments within the industry.
This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.